Search Results - Birgit Strobl

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Editorial: Women in molecular innate immunity by Francesca Granucci, Laura Marongiu, Birgit Strobl

    Published in Frontiers in Immunology (2023-07-01)
    Get full text
    Article


  2. 2

    In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity by Michaela Prchal-Murphy, Agnieszka Witalisz-Siepracka, Karoline T Bednarik, Eva Maria Putz, Dagmar Gotthardt, Katrin Meissl, Veronika Sexl, Mathias Müller, Birgit Strobl

    Published in OncoImmunology (2015-11-01)
    Get full text
    Article


  3. 3

    Lack of TYK2 signaling enhances host resistance to Candida albicans skin infection by Sara Miranda, Caroline Lassnig, Kristina Schmidhofer, Hrönn Kjartansdottir, Claus Vogl, Simone Tangermann, Irina Tsymala, Verena Babl, Mathias Müller, Karl Kuchler, Birgit Strobl

    Published in Nature Communications (2024-12-01)
    Get full text
    Article


  4. 4

    The C-Terminal Transactivation Domain of STAT1 Has a Gene-Specific Role in Transactivation and Cofactor Recruitment by Matthias Parrini, Katrin Meissl, Mojoyinola Joanna Ola, Therese Lederer, Ana Puga, Sebastian Wienerroither, Pavel Kovarik, Thomas Decker, Mathias Müller, Mathias Müller, Birgit Strobl

    Published in Frontiers in Immunology (2018-12-01)
    Get full text
    Article


  5. 5

    Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex by Sebastian Wienerroither, Priyank Shukla, Matthias Farlik, Andrea Majoros, Bernadette Stych, Claus Vogl, HyeonJoo Cheon, George R. Stark, Birgit Strobl, Mathias Müller, Thomas Decker

    Published in Cell Reports (2015-07-01)
    Get full text
    Article


  6. 6

    Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection. by Elisabeth Kernbauer, Verena Maier, Dagmar Stoiber, Birgit Strobl, Christine Schneckenleithner, Veronika Sexl, Ursula Reichart, Boris Reizis, Ulrich Kalinke, Amanda Jamieson, Mathias Müller, Thomas Decker

    Published in PLoS Pathogens (2012-01-01)
    Get full text
    Article


  7. 7

    Tyk2 is a tumor suppressor in colorectal cancer by Stefan Moritsch, Bernadette Mödl, Irene Scharf, Lukas Janker, Daniela Zwolanek, Gerald Timelthaler, Emilio Casanova, Maria Sibilia, Thomas Mohr, Lukas Kenner, Dietmar Herndler-Brandstetter, Christopher Gerner, Mathias Müller, Birgit Strobl, Robert Eferl

    Published in OncoImmunology (2022-12-01)
    Get full text
    Article


  8. 8

    TYK2 kinase activity is required for functional type I interferon responses in vivo. by Michaela Prchal-Murphy, Christian Semper, Caroline Lassnig, Barbara Wallner, Christian Gausterer, Ingeborg Teppner-Klymiuk, Julianna Kobolak, Simone Müller, Thomas Kolbe, Marina Karaghiosoff, Andras Dinnyés, Thomas Rülicke, Nicole R Leitner, Birgit Strobl, Mathias Müller

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  9. 9

    Lipocalin 2 modulates dendritic cell activity and shapes immunity to influenza in a microbiome dependent manner. by Martin L Watzenboeck, Barbara Drobits, Sophie Zahalka, Anna-Dorothea Gorki, Asma Farhat, Federica Quattrone, Anastasiya Hladik, Karin Lakovits, Gabriel M Richard, Therese Lederer, Birgit Strobl, Gijs A Versteeg, Louis Boon, Philipp Starkl, Sylvia Knapp

    Published in PLoS Pathogens (2021-04-01)
    Get full text
    Article


  10. 10

    STAT1 is a sex‐specific tumor suppressor in colitis‐associated colorectal cancer by Ilija Crnčec, Madhura Modak, Claire Gordziel, Jasmin Svinka, Irene Scharf, Stefan Moritsch, Paulina Pathria, Michaela Schlederer, Lukas Kenner, Gerald Timelthaler, Mathias Müller, Birgit Strobl, Emilio Casanova, Editha Bayer, Thomas Mohr, Johannes Stöckl, Karlheinz Friedrich, Robert Eferl

    Published in Molecular Oncology (2018-04-01)
    Get full text
    Article


  11. 11

    STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity by Katrin Meissl, Natalija Simonović, Lena Amenitsch, Agnieszka Witalisz-Siepracka, Agnieszka Witalisz-Siepracka, Klara Klein, Klara Klein, Caroline Lassnig, Caroline Lassnig, Ana Puga, Claus Vogl, Andrea Poelzl, Markus Bosmann, Markus Bosmann, Alexander Dohnal, Veronika Sexl, Mathias Müller, Mathias Müller, Birgit Strobl

    Published in Frontiers in Immunology (2020-09-01)
    Get full text
    Article


  12. 12

    Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade by Katharina Woess, Sabine Macho-Maschler, Dorette S. van Ingen Schenau, Miriam Butler, Caroline Lassnig, Daniel Valcanover, Andrea Poelzl, Katrin Meissl, Barbara Maurer, Tania Brandstoetter, Claus Vogl, Anna Koren, Stefan Kubicek, Anna Orlova, Richard Moriggl, Birgit Strobl, Veronika Sexl, Frank N. van Leeuwen, Roland P. Kuiper, Mathias Mueller

    Published in Haematologica (2022-01-01)
    Get full text
    Article


  13. 13

    JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression by Torben Redmer, Martin Raigel, Christina Sternberg, Roman Ziegler, Clara Probst, Desiree Lindner, Astrid Aufinger, Tanja Limberger, Karolina Trachtova, Petra Kodajova, Sandra Högler, Michaela Schlederer, Stefan Stoiber, Monika Oberhuber, Marco Bolis, Heidi A. Neubauer, Sara Miranda, Martina Tomberger, Nora S. Harbusch, Ines Garces de los Fayos Alonso, Felix Sternberg, Richard Moriggl, Jean-Philippe Theurillat, Boris Tichy, Vojtech Bystry, Jenny L. Persson, Stephan Mathas, Fritz Aberger, Birgit Strobl, Sarka Pospisilova, Olaf Merkel, Gerda Egger, Sabine Lagger, Lukas Kenner

    Published in Molecular Cancer (2024-05-01)
    Get full text
    Article


Search Tools: